Earli

Oncology Therapeutics · Drug Discovery
Sponsors visas
2Open roles
$235kMedian advertised pay

Facts

as of Nov 17, 2026

Earli is a biotechnology company developing a BioAI approach to cancer therapy in which drugs are produced only in the tumor, by the tumor. Its aim is to avoid systemic toxicity and enable localized immune activation, and it hires scientists in bio AI and in vivo pharmacology. The company is headquartered in Redwood City, United States.

It is hiring: 2 open roles, 0 of them posted in the last 30 days.

Headquarters
Redwood City, United States
Employees
11-50estimated range
Open roles
2Alion job postings
Website
earli.com

As of Nov 17, 2026, Alion lists 2 open roles at Earli. Earli is headquartered in Redwood City, United States. It has raised $145M in 2 funding rounds. The latest round is Venture - Series Unknown of $105M, announced in 2026.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Hiring slowly: few roles were posted lately.

Biotech is the largest family, 100 of open roles.

0%Remote roles0 of 2
1Roles in AI50% of open roles
1Hiring offices
Can they hire you from United States?by your location
Likely
2 open roles are in your country: you apply locally, no move needed.
United States2On site
Remote, from elsewhere0Rare
No posting offers visa sponsorship. Remote roles: 0.
Alion signals0-100
Demand22
Pay35
Your chance47
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 21This week
Open roles a week: 2 then, 0 now
Where the openings areshare of open roles · trend
Biotech100▼
Newest roles
Sr Director, In Vivo Pharmacology
$215k – $235k per year · In office · PhD · Redwood City
Senior Scientist, Bio AI
$205k – $235k per year · In office · 3+ years exp · Master's Degree · Redwood City
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

Pay

What its postings pay, by level.

$235kMedian
$235kTypical rangeUSD a year
$235kHighest paying roleSenior Scientist, Bio AI
Source: the pay stated in the company's postings, normalised to USD a year

Named in the work visa registers of United States.

United StatesUS 3 #3,445 of 8,997 sponsors
3 ▲ 50%H-1B filings in 12 months
$143kMedian offered salary
2Open roles in United States
Who they sponsor
Biological technicians1
Biochemists and biophysicists1
Other biological scientists1
The salary offered for each occupationVisa pass · 90 credits

In the register as Earli Inc., Redwood City, CA

Other sponsors in the same field
See 2 open roles Alert me
US Department of Labor · latest filing May 22, 2026

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
Redwood CityBusiest site
SiteTypeOpen rolesHires most forEngineering
Redwood City United StatesHeadquarters2AI/ML, Biotech50%
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$145MTotal raised
Venture - Series UnknownLatest round
2Rounds and grants
Money by yearUSD, rounds and grants
2026$105M1 record
2021$40M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Tech stack

Technologies named in job postings at Earli over the last 12 months, by layer, with the share of postings for each.

8Technologies in use
2Postings analysed
66/100Stack modernity
LanguagesPythonR
Frameworks & librariesShiny
Cloud & platformsGCP
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site

Milestones

Jan 11, 2021
Each milestone is dated by its source: registers, filings, the press

Newsroom

Apr 152026
Mar 172026
News · BiotechTV
Co-Founder & CEO Cyriac Roeding and Co-Founder & CSO David Suhy describe the science behind this approach and explain how AI is helping they move closer to the clinic. The first…
Dec 19, 20242024
News · Entrepreneur
What happens when a Silicon Valley entrepreneur, a synthetic biology expert, and a world-renowned cancer researcher team up? They create Earli-a startup rewriting the rules of ca…
Aug 20, 20242024
News · Pharmaceutical Technology
Accenture has made an investment in biotechnology company Earli for advancing early cancer detection technologies.
Aug 19, 20242024
Press release · businesswire
Accenture has made a strategic investment, through Accenture Ventures, in Earli Inc., a biotechnology company.
Sources: the outlets named on each headline, each story once